- Transurethral Resection of Non-muscle-invasive Bladder Cancer2009 | First Faculty of Medicine
- Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective2022 | Second Faculty of Medicine
- En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?2020 | Second Faculty of Medicine
- Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer2013 | Second Faculty of Medicine
- An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer2018 | Second Faculty of Medicine
- Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis2023 | Second Faculty of Medicine
- Re: Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-grade Non-muscle-invasive Bladder Cancer on Tumor Recurrence2019 | Second Faculty of Medicine
- Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer2017 | Second Faculty of Medicine
- Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer2022 | Second Faculty of Medicine
- Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies2021 | Second Faculty of Medicine
- Treatment of muscle invasive bladder cancer2008 | First Faculty of Medicine
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | First Faculty of Medicine, Second Faculty of Medicine
- Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review2017 | First Faculty of Medicine, Second Faculty of Medicine
- Using photodynamic diagnosis and narrow band imaging for diagnosing and treating non-muscle-invasive bladder cancer2013 | Second Faculty of Medicine
- Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey2019 | Second Faculty of Medicine
- The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis2023 | Second Faculty of Medicine
- Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non-muscle-invasive Bladder Cancer2013 | Second Faculty of Medicine
- Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non-Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations2010 | Second Faculty of Medicine
- Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guerin: Results of a Retrospective Multicenter Study of 2451 Patients2015 | First Faculty of Medicine, Second Faculty of Medicine
- Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial2023 | Second Faculty of Medicine
- Treatment of low-risk non-muscle-invasive bladder cancer2012 | Second Faculty of Medicine
- Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature2013 | Second Faculty of Medicine
- Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel2020 | First Faculty of Medicine, Second Faculty of Medicine
- A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment after Transurethral Resection2021 | Second Faculty of Medicine
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel2021 | First Faculty of Medicine, Second Faculty of Medicine
- How to predict the risk of complication or death after radical cystectomy?2015 | Second Faculty of Medicine
- Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study2024 | Second Faculty of Medicine
- Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?2018 | First Faculty of Medicine, Second Faculty of Medicine
- How to prevent recurrence and progression in non-muscle invasive bladder cancer2008 | First Faculty of Medicine
- Narrow Band Imaging Cystoscopy Improves the Detection of Non-muscle-invasive Bladder Cancer2010 | First Faculty of Medicine